Prevention of recurrent respiratory papillomatosis: Role of HPV vaccination
- 1 October 2006
- journal article
- review article
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 70 (10) , 1799-1803
- https://doi.org/10.1016/j.ijporl.2006.06.006
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial NeoplasiaObstetrics & Gynecology, 2006
- Recurrent respiratory papillomatosis: bright prospects for vaccine-based preventionPapillomavirus Report, 2005
- PS10 Late breaking Prophylactic use of quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine reduces cervical intraepithelial neoplasia (CIN) 2/3 and adenocarcinoma in situ (AIS) riskEuropean Journal of Cancer Supplements, 2005
- Predictors of Remission in Juvenile-Onset Recurrent Respiratory PapillomatosisJAMA Otolaryngology–Head & Neck Surgery, 2003
- National Registry for Juvenile-Onset Recurrent Respiratory PapillomatosisJAMA Otolaryngology–Head & Neck Surgery, 2003
- Condyloma in pregnancy is strongly predictive of Juvenile-Onset recurrent respiratory papillomatosisObstetrics & Gynecology, 2003
- A Controlled Trial of a Human Papillomavirus Type 16 VaccineNew England Journal of Medicine, 2002
- Initial Results From the National Registry for Juvenile-Onset Recurrent Respiratory PapillomatosisJAMA Otolaryngology–Head & Neck Surgery, 1999
- Task Force on Recurrent Respiratory Papillomas: A Preliminary ReportJAMA Otolaryngology–Head & Neck Surgery, 1995
- Juvenile laryngeal papillomatosis. An epidemiological study from the Copenhagen regionActa Oto-Laryngologica, 1988